HydroPICC
Commercial- Indications
- Vascular access
Company intelligence / Profile preview
Access Vascular
Billerica, Massachusetts, United Statesaccessvascularinc.com ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Commercial
01
Overview
Access Vascular’s FDA-cleared HydroPICC® and HydroMID® catheters have demonstrated significant reductions in complications such as thrombosis, occlusions, replacements, deep vein thrombosis (DVT), and phlebitis compared to standard polyurethane catheters. Clinical data show up to a sixfold decrease in complications and some studies report as much as a complete elimination of certain issues like occlusions or DVTs versus traditional devices. The company’s technology has been validated by multiple awards and growing adoption in U.S. hospitals.
- Therapeutic areas
- OtherCardiovascularHematology
- Modalities
- DeviceHydrophilic biomaterial-based device
- Industry
- Surgical Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Healthcare Insights (“HCIS”)—collaboration on value-based care program development with focus on hospital outcomes improvement
Beyond the preview
Go deeper on Access Vascular.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Access Vascular.